Avenue Solutions

Avenue Solutions filed a Q1 report for Illumina, Inc. on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Illumina, Inc. · Sequencing and array-based solutions for genetic research, clinical and applied markets

As filed: AVENUE SOLUTIONS for ILLUMINA, INC.

All filings by Avenue Solutions · Everything Illumina, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence

Trade (domestic/foreign)

General trade issues

Bills named in this filing 2

H.R. 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S. 339
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.